Loredana Santo

Loredana Santo

Centers for Disease Control and Prevention - Atlanta / United States
Medical and Health Sciences / Epidemiology and Public Health
AD Scientific Index ID: 1416688
person_outline Loredana Santo's MOST POPULAR ARTICLES
1-) Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myelomaL Santo, T Hideshima, AL Kung, JC Tseng, D Tamang, M Yang, M Jarpe, ...Blood, The Journal of the American Society of Hematology 119 (11), 2579-2589, 20125802012
2-) Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myelomaN Mimura, M Fulciniti, G Gorgun, YT Tai, D Cirstea, L Santo, Y Hu, ...Blood, The Journal of the American Society of Hematology 119 (24), 5772-5781, 20124042012
3-) Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myelomaM Ladetto, G Pagliano, S Ferrero, F Cavallo, D Drandi, L Santo, C Crippa, ...Journal of Clinical Oncology 28 (12), 2077-2084, 20103282010
4-) The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitorsEA Nelson, SR Walker, E Weisberg, M Bar-Natan, R Barrett, LB Gashin, ...Blood, The Journal of the American Society of Hematology 117 (12), 3421-3429, 20113352011
5-) A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myelomaG Görgün, E Calabrese, T Hideshima, J Ecsedy, G Perrone, M Mani, ...Blood, The Journal of the American Society of Hematology 115 (25), 5202-5213, 20103262010